Thermo Fisher Scientific Inc., has reported its financial results for the second quarter ended June 29, 2013.

Second Quarter 2013 Highlights

  • Adjusted earnings per share (EPS) grew 8% to a second quarter record of $1.32
  • Revenue increased 4% to $3.24 billion, a second quarter record
  • Adjusted operating margin expanded 30 basis points to 19.3%
  • Reinforced innovation leadership at ASMS with launch of three mass spectrometry platforms offering unprecedented analysis and ease of http://casinodom.net use for life sciences research and applied markets
  • Continued to strengthen R&D capabilities in Asia-Pacific by establishing new China Innovation and Technology Training Center for healthcare, environmental and food safety customers
  • Secured significant portion of debt and equity financing to fund pending acquisition of Life Technologies
By | 2013-10-02T11:56:31+00:00 July 26th, 2013|Categories: Antibody Suppliers|Tags: , , |0 Comments

Leave A Comment